Health and Human Services Secretary Robert F. Kennedy Jr. appeared before federal lawmakers on Tuesday, April 21, 2026, to address contentious issues regarding federal health spending and immunization policy. During his testimony before the House Committee on Energy and Commerce Subcommittee on Health, Kennedy defended proposed reductions to the National Institutes of Health while declining to guarantee that he would automatically follow vaccine guidance issued by the newly nominated CDC director.
The hearing marked the conclusion of a four-part series of budget inquiries conducted by House members. Lawmakers questioned Kennedy about the Trump administration’s fiscal year 2027 budget request, which includes significant adjustments to federal research funding and health programs.
Budget Cuts and NIH Funding
Rep. Lizzie Fletcher, a Democrat from Texas, expressed concern over proposed reductions to federal research aid within the administration’s latest budget proposal. Kennedy acknowledged that the cuts were difficult but framed them as necessary fiscal measures.
Kennedy stated that HHS was instructed to reduce its $100 million budget by 12 percent. He cited the nation’s overall financial position to justify the reductions, noting the scale of federal liabilities.
“We have a $35 trillion debt… we’re making cuts that are painful,” Kennedy told the subcommittee, as first reported by the ABC News.
Despite the broader reductions, Kennedy highlighted that his department is committing $1 billion specifically toward vaccine research through the NIH and the National Cancer Institute. This funding allocation stands in contrast to the overall budget contraction discussed during the hearing.
Vaccine Policy and CDC Leadership
A significant portion of the hearing focused on immunization policy and the upcoming leadership at the Centers for Disease Control and Prevention. President Trump nominated Dr. Erica Schwartz as the new CDC director on April 16, 2026. Schwartz previously instituted disease surveillance and vaccination programs during her tenure with the Coast Guard.
Kennedy confirmed that he had reviewed Schwartz’s positions on vaccines prior to her nomination. However, when pressed by lawmakers, he stopped short of committing to fully implement all vaccine guidance issued by the CDC under her leadership. This stance has drawn scrutiny from members who argue for a more unified federal approach to public health directives.
Criticism from Democratic Lawmakers
Several Democratic representatives used the hearing to challenge Kennedy’s record and policy decisions. Rep. Marc Veasey, also from Texas, characterized Kennedy as the most “anti-vax” figure he had encountered in his lifetime. Veasey pointed to recent public health data to support his criticism.
Veasey noted that two unvaccinated school-aged children died from measles last year, marking the first U.S. deaths from the disease in a decade. He also cited CDC data showing that at least 138,000 kindergarteners were exempt from one or more vaccines during the most recent school year. According to Veasey, MMR vaccine rates have steadily decreased over the last decade.
Rep. Raul Ruiz of California directed his questions toward Kennedy’s management of the CDC. Ruiz criticized the secretary for firing former CDC director Susan Monarez. Monarez had testified at a Senate hearing in September 2025, stating she was removed from her position for “holding the line on scientific integrity.”
The exchange highlighted ongoing tensions between the administration and some lawmakers regarding the role of scientific consensus in public health policy. Kennedy did not directly address the specific circumstances of Monarez’s departure during this hearing but maintained that his department’s actions align with the administration’s broader health goals.
Idaho Context and Next Steps
The developments in Washington have implications for Idaho, where state health officials and local school boards navigate federal guidance on immunizations. The Idaho Department of Health and Welfare monitors CDC recommendations while managing state-specific vaccination requirements. As the new fiscal year approaches, Idaho lawmakers may need to consider how federal budget shifts affect state-level health programs and research grants.
The House subcommittee’s questioning signals continued scrutiny of HHS policies. With Dr. Schwartz’s confirmation process ongoing, the final structure of CDC vaccine guidance remains a key point of contention. Kennedy’s refusal to fully endorse future CDC directives suggests that inter-agency coordination on immunization policy will remain a focal point for congressional oversight in the coming months.
For more on federal health policy developments, see Supreme Court Leaves New York Healthcare Worker Vaccine Mandate Ruling Standing. Readers interested in related agricultural and health initiatives may also review Trump Signs Executive Order Directing Federal Agencies to Advance Regenerative Agriculture.